Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0334 per EA under NDC 63304077210. Its NADAC has been published 133 times since Feb 7, 2024.
FDA first approved this application on Aug 29, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304077210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA076045FDA Approved
8/29/2001
TE Code
AB
On Market Since
6/25/2023
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 133 times since Feb 7, 2024, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0334 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0315 (Nov 20, 2024) |
| 52-week high | $0.0430 |
| 52-week low | $0.0328 |
| Median price | $0.0420 |
| Average price | $0.0400 |
| Largest weekly change | +28.1% (Aug 21, 2024) |
| Weeks tracked | 133 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0334 per EA (NDC 63304077210), effective Aug 19, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 26.2%. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Feb 7, 2024, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0315 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0420 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 39% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 63304077210) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.